desipramine has been researched along with Child Behavior Disorders in 7 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Child Behavior Disorders: Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 6-week randomized, double-blind, placebo controlled trial of desipramine (DMI) in daily doses averaging 4 to 5 mg/kg for the treatment of children and adolescents with attention deficit disorder with hyperactivity (ADDH) was further analyzed." | 5.07 | A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response. ( Baldessarini, RJ; Biederman, J; Faraone, S; Keenan, K; Wright, V, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mikkelsen, EJ | 1 |
| Rapoport, JL | 1 |
| Biederman, J | 1 |
| Baldessarini, RJ | 1 |
| Wright, V | 1 |
| Keenan, K | 1 |
| Faraone, S | 1 |
| Rowe, JB | 1 |
| Sullivan, PF | 1 |
| Mulder, RT | 1 |
| Joyce, PR | 1 |
| Varley, CK | 1 |
| Al-Mateen, CS | 1 |
| Wolf, CE | 1 |
| Warnock, JK | 1 |
| Sieg, K | 1 |
| Willsie, D | 1 |
| Stevenson, EK | 1 |
| Kestenbaum, T | 1 |
| Winsberg, BG | 1 |
| Perel, JM | 1 |
| Hurwic, MJ | 1 |
| Klutch, A | 1 |
1 review available for desipramine and Child Behavior Disorders
| Article | Year |
|---|---|
Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms and clinical implications.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Child Behavior Disorders; Death, Sudden; Desipr | 2001 |
3 trials available for desipramine and Child Behavior Disorders
| Article | Year |
|---|---|
Enuresis: psychopathology, sleep stage, and drug response.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Child Behavior Disorders; Cli | 1980 |
A double-blind placebo controlled study of desipramine in the treatment of ADD: III. Lack of impact of comorbidity and family history factors on clinical response.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior Disorders; Comorbid | 1993 |
The effect of a history of conduct disorder in adult major depression.
Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Tricyclic; Child; Child Behavior Disorders; Cl | 1996 |
3 other studies available for desipramine and Child Behavior Disorders
| Article | Year |
|---|---|
Falsely elevated imipramine levels in a patient taking quetiapine.
Topics: Child; Child Behavior Disorders; Chromatography, High Pressure Liquid; Desipramine; Dibenzothiazepin | 2002 |
Drug-related alopecia in patients treated with tricyclic antidepressants.
Topics: Adult; Alopecia; Antidepressive Agents, Tricyclic; Anxiety Disorders; Child; Child Behavior Disorder | 1991 |
Imipramine protein binding and pharmacokinetics in children.
Topics: Age Factors; Blood Proteins; Carbon Radioisotopes; Child Behavior Disorders; Desipramine; Dose-Respo | 1974 |